CAR T-Cell Therapy: Delving Into Evolving Topics, Critical Aspects of Management, and Practice-Changing Data

Engage with this series of 6 ClinicalThought expert commentaries designed to keep you up to date over time with the latest findings in CAR T-cell therapy. A downloadable slideset based on the commentaries will help apply the education in the clinic or in your own presentations.

Share

Program Content

Activities

CAR T-Cell Trials in RRMM
What’s New With CAR T-Cell Therapies for Relapsed/Refractory Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 16, 2019

Expires: August 15, 2020

CAR T: Patient Education
Educating Patients and Caregivers About CAR T-Cell Therapies: A Nursing Perspective
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 09, 2019

Expires: September 08, 2020

CAR T Combination Therapy
Leveraging CAR T-Cell Combinations to Overcome Nonresponse and Relapse
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 10, 2019

Expires: September 09, 2020

Pharmacists and CAR T AEs
The Pharmacist’s Role in Managing CAR T-Cell–Associated Toxicities
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 17, 2020

Expires: February 16, 2021

ASH 2019: CAR T
My Take on Key Studies in CAR T-Cell Therapy From ASH 2019
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 31, 2020

Expires: January 30, 2021

CAR T for Real-World Pts
How to Identify and Optimize “Real-World” Patients for CAR T-Cell Therapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 04, 2020

Expires: March 03, 2021

Activities

CAR T: Expert Slides
Expert View on CAR T-Cell Therapy: Delving Into Evolving Topics, Critical Aspects of Management, and Practice-Changing Data
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 24, 2020

Expires: March 23, 2021

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Celgene

Gilead